Is it the claimed substance?
Identity testing compares a sample response with a suitable reference. The certificate should name the method and the material identified.
Testing foundations · C-022
Peptide testing and certificates of analysis
Start with the question the evidence can answer. A certificate describes a sample and a test result. It does not, by itself, prove that the sample came from your vial or that every relevant attribute was measured.
Peptide testing can support a claim about identity, purity, quantity, sterility, endotoxin or another defined attribute only when a suitable analytical method measured that attribute. A certificate of analysis, or COA, records the result. Its value depends on the method, sample, laboratory, document integrity and match to the physical vial.
This hub separates document evidence from sample evidence. Use it to read a COA, understand a method's scope, assess laboratory independence, recognise document red flags and match a certificate to a vial and batch. It does not recommend products, suppliers or use.
Six separate attributes
One result cannot answer every testing question
Each card names a different measurand or quality attribute. Look for an explicit method and result for the attribute you need. Silence is not a pass.
How much of the measured profile is the main component?
A chromatographic purity figure concerns the detected components under stated conditions. It is not automatically a mass fraction, dose or identity result.
How much material is present?
Assay or content testing needs its own method, calibration and units. A purity percentage alone does not establish milligrams in a vial.
Were viable microorganisms detected?
Sterility is a separate microbiological question. Chemical identity or purity testing does not answer it.
Was bacterial endotoxin assessed?
Endotoxin testing is distinct from sterility and chemical analysis. The report needs a method, limit and result.
What else was targeted?
Residual solvents, elemental impurities and other contaminants require defined targets. Untargeted hazards may remain outside the test scope.
The central distinction
Keep document evidence and sample evidence apart
Document evidence asks whether the certificate is coherent, attributable and verifiable. Check the laboratory, method, dates, sample description, batch reference, specification, result and authorised sign-off.
Sample evidence asks what was tested, how the sample was obtained, whether custody was recorded and whether that sample represents the vial or batch being evaluated.
A polished PDF can be a genuine laboratory document yet belong to another sample. A correctly matched document can still have a narrow test scope. Both layers must hold before you rely on the result for the stated attribute.
Start with reading a certificate, then check what the method measured.
Evidence boundary
- A COA may establish
- What the document reports for the described sample
- It does not establish alone
- That the sample came from your vial
- It cannot extend beyond
- The method, detection capability and sample scope
- Decision rule
- Record silence, inconsistency and uncertainty explicitly
Method-to-claim matrix
Read a method as a bounded measurement
The method name is a starting point, not a verdict. The intended purpose, validation, preparation, reference materials, reporting units and decision criteria determine what the result supports.
| Question | Method family often used | What to verify | What remains outside that result |
|---|---|---|---|
| Identity | Mass spectrometry or a suitably specific spectroscopic comparison | Reference, acceptance criteria and whether the signal is specific enough for the claimed substance | Quantity, sterility, endotoxin and clinical safety |
| Purity profile | Liquid chromatography | Detection conditions, integration, calculation basis and which components can be seen | Identity unless separately confirmed; total vial content; undetected contaminants |
| Quantity or assay | Validated quantitative assay | Calibration, units, reference standard, sample preparation and uncertainty | Sterility, endotoxin and effects in people |
| Sterility | Compendial microbiological test | Sample plan, method suitability, conditions and reported outcome | Endotoxin and chemical identity |
| Endotoxin | Bacterial endotoxin test | Method, interference controls, limit and units | All viable microorganisms and chemical contaminants |
Interpretation limit
“Tested” has little meaning without the attribute, method, sample and result. A test panel is only as broad as the questions it was designed to answer.
Verification route
Use the pages in this order
01
Read
Identify every field, the result reported and any missing information.
02
Measure
Connect each analytical procedure with the attribute it can support.
03
Authenticate
Confirm the laboratory, document and issue record before relying on the file.
04
Match
Connect the tested sample, batch reference and physical vial.
Choose the guide for your question
Certificate anatomyRead a peptide COACheck every field and classify it as adequate, silent or inconsistent.
Analytical scopeWhat tests can proveSeparate identity, purity, quantity, sterility, endotoxin and contaminants.
IndependenceWhat independent testing addsAssess commissioning, sample provenance, accreditation scope and custody.
Document integrityConfirm the certificate is genuineCheck the issuer, dates, batch, methods and verification route.
Physical matchMatch the COA to the vialCompare the batch reference, label, dates and lookup record.
Publisher incentivesWho wrote the guidance?Distinguish seller, seller-adjacent, independent and official sources.
Editorial method
How we apply the evidence boundary
Our topical map treats a document, a tested sample and a consumer-held vial as separate entities. We preserve that separation in every test interpretation. We record the measurand, method, sample reference, laboratory, result and limitation before writing a conclusion. We do not convert a missing result into an implied pass.
Sources for this foundation include the UK Accreditation Service explanation of ISO/IEC 17025 laboratory accreditation, the ICH Q2(R2) framework for demonstrating that an analytical procedure is fit for its intended purpose, WHO expectations for laboratory and batch records in active pharmaceutical ingredient manufacture, and Eurachem guidance on uncertainty arising from sampling.
- UKAS: laboratory accreditation · competence, impartiality and consistent operation under ISO/IEC 17025.
- ICH Q2(R2) via FDA · validation of analytical procedures for their intended purpose.
- WHO GMP for active pharmaceutical ingredients · laboratory records, sample references, batch records and review expectations.
- Eurachem: uncertainty from sampling · the effect of sampling on a measurement result and its uncertainty.
Scope: These official frameworks explain analytical and record-keeping principles. Their inclusion does not establish that a particular seller, laboratory, product or certificate complies. Sources checked 7 August 2026.
Editorial experience
From our work: how we checked this page
For topical-map item C-022, Peptide testing and certificates of analysis was checked as a distinct editorial task, not treated as a generic peptide page. We reviewed 4 unique external sources and 8 internal destinations in the page, then checked that the opening answer, headings, source descriptions and linked next steps stayed within the same claim boundary. The count records links in the published page and is not a claim that every source carries equal evidential weight.
Eleni Kiromitis checked the laboratory and scientific wording, drawing on direct experience commissioning laboratory tests and reviewing certificates of analysis and chromatograms. She checked whether each method was matched to the attribute it can measure, whether sample and batch limits remained visible, and whether the conclusion stopped where the analytical record stopped. Yianni Kiromitis retained responsibility for source verification, editorial decisions and correction management.
We did not use patient experience, a personal treatment outcome, seller testimony or an assumed product identity to support this page. The publication did not independently test a vial for this review. Where a page refers to a laboratory result, that result applies only to the named sample, method and attribute. We kept uncertainty beside the conclusion, recorded which source supports each material claim, and checked that the visible review date matches the publication record. A new controlled study, regulator update, corrected source, analytical report or credible safety signal can trigger reassessment through the public correction route.